Breast Cancer Drug Underused, Study Says
The drug tamoxifen has been shown to cut breast cancer risk by nearly 50 percent, yet many women at high risk of the disease are not taking the medication.
A study in the March 22 online edition of Cancer finds only 63 percent of women were offered the drug and only 26 percent accepted it. The authors believe physician practices and the attitudes of at-risk women are responsible for the low rates of tamoxifen use.